Moleculin Biotech Inc.
MBRX | NASDAQ
$0.52
-$0.25 (-32.74%)
At close: Sep 21, 2026, 4:00 PM ET
$0.55
+$0.03 (+5.56%)
Pre-market:
Sep 22, 2026, 5:50 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 90K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -90K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -25.1M | -26.64M | -29.63M | -30.64M | -22.97M | -19.74M |
Interest Income | 105K | 550K | 1.37M | 240K | 306K | 13K |
Pretax Income | -33.56M | -21.76M | -29.77M | -29.03M | -15.89M | -17.36M |
Net Income | -33.56M | -21.76M | -29.77M | -29.03M | -15.89M | -17.36M |
Selling & General & Admin | 9.12M | 8.79M | 10.02M | 11.54M | 8.39M | 6.79M |
Research & Development | 15.89M | 17.73M | 19.49M | 18.97M | 14.42M | 12.76M |
Other Expenses | 90K | 126K | 127K | 130K | 164K | 200K |
Operating Expenses | 25.1M | 26.64M | 29.63M | 30.64M | 22.97M | 19.74M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 25.1M | 26.64M | 29.63M | 30.64M | 22.97M | 19.74M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.18M | 137.72K | 79.02K | 76.28K | 71.67K | 26.26K |
Shares Outstanding (Diluted) | 1.18M | 137.72K | 79.02K | 76.28K | 71.67K | 26.26K |
EPS (Basic) | -28.42 | -189.14 | -376.71 | -380.51 | -221.77 | -661 |
EPS (Diluted) | -28.42 | -189.14 | -376.71 | -380.51 | -221.77 | -661 |
EBITDA | -33.47M | -21.64M | -29.64M | -28.9M | -15.73M | -19.54M |
EBIT | -33.56M | -21.76M | -29.77M | -29.03M | -15.89M | -19.74M |
Depreciation & Amortization | 90K | 126K | 127K | 130K | 164K | 200K |
Add to Watchlist
Select watchlists to add or remove MBRX